Darshak Patel, MD
Family Medicine · Framingham, MANPI 1689178824
Payments from drug & device makers
Across 99 payments — averaging $19.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$241
- Sanofi-aventis U.S. LLC$210
- GSK$183
- AbbVie$171
- Abbott$170
- Boehringer Ingelheim$148
- plus $855 from 17 others
What the payments were for
- Food & beverage$1,978100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 12 | $241 |
| Sanofi-aventis U.S. LLC | 12 | $210 |
| GSK | 11 | $183 |
| AbbVie | 7 | $171 |
| Abbott | 9 | $170 |
| Boehringer Ingelheim | 6 | $148 |
| Pfizer | 7 | $136 |
| Lilly USA, LLC | 5 | $116 |
| Johnson & Johnson | 5 | $86 |
| Nestle Healthcare Nutrition Inc. | 3 | $73 |
| Xeris Pharmaceuticals, Inc. | 3 | $63 |
| Paratek Pharmaceuticals, Inc. | 3 | $62 |
| Novartis | 3 | $61 |
| Bayer | 3 | $49 |
| Merck | 2 | $37 |
| Amgen | 1 | $27 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $24 |
| Daiichi Sankyo Inc. | 1 | $23 |
| Eisai Inc. | 1 | $22 |
| Neurelis, Inc. | 1 | $22 |
| AstraZeneca | 1 | $21 |
| Amarin Pharma, Inc. | 1 | $20 |
| Kyowa Kirin, Inc. | 1 | $13 |
How this compares
$1,978 in reported general payments places this provider in the 85th percentile of 1,049 family medicine providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 35 | $907 |
| Oxycodone Hcl | 37 | $532 |
| Pravastatin Sodium | 27 | $508 |
| Diclofenac Sodium | 30 | $386 |
| Levothyroxine Sodium | 41 | $374 |
| Atorvastatin Calcium | 38 | $349 |
| Losartan Potassium | 24 | $340 |
| Gabapentin | 40 | $340 |
| Amlodipine Besylate | 31 | $280 |
| Doxycycline Monohydrate | 32 | $274 |
| Pantoprazole Sodium | 26 | $255 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 31 | $240 |
| Lisinopril | 26 | $230 |
| Omeprazole | 13 | $205 |
| Hydroxyzine Hcl | 13 | $160 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Framingham
- Megan McCoyFramingham$75K
- Sanjeev SharmaFramingham$21K
- Robert BeckWestford$2.1M
- Katherine Gergen BarnettBoston$226K
- Peter O'DwyerBoston$163K
- Kelly LannuttiWeymouth$122K
- Larry CulpepperBoston$109K
- Jennifer WeylerWorcester$105K
- Kristina GraceyWorcester$73K
- Suzanne MitchellBoston$69K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.